The last DHHS contract for a smallpox vaccine stockpile was worth up to $2.8 Billion, just to add that contract went to SIGA, PHARMATHENE [PIP] contested the award due to the fact that they had an agreement in place to purchase the technology then SIGA reneged.
PHARMATHENE won the lawsuit as I and others thought completely plausible, that was a nice trade...I digress
What I am meandering about is as I have posted before, would be great to spin off the Infectious disease arm to shareholders as a separate entity in view of the terrible 1/100 R/S we had to endure. Have seen it happen before so not out of the realm of speculation.
BLU
Market Data 
Markets 
AI
